Evidence map›Paper›PMID 33961029›Full record

ReviewEndocrine reviews2022

Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Hedi L Claahsen-van der Grinten, Phyllis W Speiser, S Faisal Ahmed, Wiebke Arlt, Richard J Auchus, Henrik Falhammar, Christa E Flück, Leonardo Guasti, Angela Huebner, Barbara B M Kortmann and 11 more

Open access · greenAbstract readReview
In one paragraph

Review in Endocrine reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 277 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed, 5 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 5 syntheses or guidelines pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. 17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases.The Journal of clinical endocrinology and metabolism · 2025
    Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Approach to the patient: investigation of postmenopausal androgen excess.The Journal of clinical endocrinology and metabolism · 2026
    Review
  20. Article

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 17 institutions in 8 countries.

Hedi L Claahsen-van der GrintenDepartment of Pediatric Endocrinology, Radboud University Medical Centre, Amalia Childrens Hospital, Nijmegen, The Netherlands.ORCID 0000-0003-0181-0403
Phyllis W SpeiserCohen Children's Medical Center of NY, Feinstein Institute, Northwell Health, Zucker School of Medicine, New Hyde Park, NY 11040, USA.ORCID 0000-0002-0565-8325
S Faisal AhmedDevelopmental Endocrinology Research Group, School of Medicine Dentistry & Nursing, University of Glasgow, Glasgow, UK.
Wiebke ArltInstitute of Metabolism and Systems Research (IMSR), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0001-5106-9719
Richard J AuchusDivision of Metabolism, Endocrinology, and Diabetes, Departments of Internal Medicine and Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA.
Henrik FalhammarDepartment of Molecular Medicine and Surgery, Karolinska Intitutet, Stockholm, Sweden.ORCID 0000-0002-5622-6987
Christa E FlückPediatric Endocrinology, Diabetology and Metabolism, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Leonardo GuastiCentre for Endocrinology, William Harvey Research Institute, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Angela HuebnerDivision of Paediatric Endocrinology and Diabetology, Department of Paediatrics, Universitätsklinikum Dresden, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0003-1338-5192
Barbara B M KortmannRadboud University Medical Centre, Amalia Childrens Hospital, Department of Pediatric Urology, Nijmegen, The Netherlands.
Nils KroneDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Deborah P MerkeNational Institutes of Health Clinical Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA.
Walter L MillerDepartment of Pediatrics, Center for Reproductive Sciences, and Institute for Human Genetics, University of California, San Francisco, CA 94143, USA.
Anna NordenströmDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Nicole ReischMedizinische Klinik IV, Klinikum der Universität München, Munich, Germany.
David E SandbergDepartment of Pediatrics, Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, MI 48109, USA.
Nike M M L StikkelbroeckRadboud University Medical Centre, Department of Endocrinology, Nijmegen, Netherlands.
Philippe TouraineDepartment of Endocrinology and Reproductive Medicine, Center for Rare Endocrine Diseases of Growth and Development, Center for Rare Gynecological Diseases, Hôpital Pitié Salpêtrière, Sorbonne University Medicine, Paris, France.ORCID 0000-0002-8462-7753
Agustini UtariDivision of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Diponegoro University, Semarang, Indonesia.
Stefan A WudySteroid Research & Mass Spectrometry Unit, Laboratory of Translational Hormone Analytics, Division of Paediatric Endocrinology & Diabetology, Justus Liebig University, Giessen, Germany.
Perrin C WhiteDivision of Pediatric Endocrinology, UT Southwestern Medical Center, Dallas TX 75390, USA.ORCID 0000-0001-6262-0289
Karolinska Institutet · SERadboud University Medical Center · NLUniversity of Michigan–Ann Arbor · USCenter for Human Genetics · USDiponegoro University · IDKlinik und Poliklinik für Psychotherapie und Psychosomatik · DELMU Klinikum · DENational Institutes of Health Clinical Center · USQueen Mary University of London · GBRadboud University Nijmegen · NLSorbonne Université · FRSouthwestern Medical CenterUniversity Hospital Carl Gustav Carus · DEUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Bern · CHUniversity of Giessen · DEUniversity of Glasgow · GB

Funding

Disorders/Differences of Sex Development (DSD) - Translational Research NetworkR01HD093450 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDBERG, DAVID ERIC, VILAIN, ERIC J. · 2018 to 2022
$3.9M
Abiraterone Acetate in Childen with Classic 21-Hydroxylase DeficiencyU01HD083493 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, PERRIN C · 2015 to 2020
$3.2M
Decision-Making for Patients Born with Differences of Sex Development (DSD)R01HD086583 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDBERG, DAVID ERIC · 2016 to 2021
$2.8M
Natural History Study of Patients with Excess AndrogenZIAHD008934 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MERKE, DEBORAH · 2013 to 2021
$238k
Biotechnology and Biological Sciences Research CouncilNICHD NIH HHS R01 HD086583NICHD NIH HHS R01 HD093450NICHD NIH HHS U01 HD083493
6 · The paper itself

Abstract

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.

Indexed as

Adrenal Hyperplasia, CongenitalHumansHydrocortisoneInfant, NewbornMutationNeonatal ScreeningSteroid 21-HydroxylaseCYP21A2 protein, humanHydrocortisoneSteroid 21-Hydroxylase21-hydroxylase deficiencyaldosteronecortisolCYP21A2glucocorticoidmineralocorticoidSteroid biosynthesis

Identifiers

PMID33961029
PMCPMC8755999
OpenAlexW3159396736

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.